Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom Sells Massarray to Whitehead Institute

NEW YORK, Jan 4 - MIT's Whitehead Institute has purchased Sequenom’s MassArray system for use in its high-throughput SNP genotyping projects, Sequenom said Thursday.

Sequenom spokesman Tom Baker said that the company has delivered a single MassArray system along with a number of consumables.

Baker declined to comment on the purchase price of the system.

The MassArray system eliminates the fluorescent tagging step that is necessary with competing SNP detection technologies, simplifying the detection process, said Baker.

The Whitehead Institute is the latest in a series of Human Genome Project contributors to purchase Sequenom’s technology, joining the National Human Genome Research Institute, the Sanger Centre in the U. K. and Germany’s National Research Center for Environment and Health.

Sequenom has also sold the MassArray to Hitachi, Gemini Genomics, Invitrogen, Ag Research Limited of New Zealand, Genaissance Pharmaceuticals, Integrated DNA technologies, American Home Products, and Metabion GmbH among other companies.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.